Parallax Volatility Advisers, L.P. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$1,458,000
+515.2%
33,857
+303.3%
0.00%
Q3 2019$237,000
-92.8%
8,396
-93.3%
0.00%
-100.0%
Q2 2019$3,313,000
+308.5%
125,000
+183.0%
0.00%
+300.0%
Q1 2019$811,000
+4.6%
44,163
-29.2%
0.00%0.0%
Q4 2018$775,000
-49.5%
62,361
-22.0%
0.00%
-50.0%
Q3 2018$1,534,000
+11700.0%
80,000
+8105.1%
0.00%
Q2 2018$13,0009750.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders